No Need for Neuromuscular Blockade in Day Case Standardised Laparoscopic Surgery. A Consecutive Retrospective Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cholecystitis
- Sponsor
- Hvidovre University Hospital
- Enrollment
- 1245
- Primary Endpoint
- Number of patients requiring neuromuscular blockade
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
This study analyse the need for neuromuscular blockade in consecutive routine laparoscopic procedures without standard use of neuromuscular blockade in an ambulatory laparoscopic surgery setting and analyse specific reasons for using neuromuscular blockade in individual patients. Furthermore, the study report the analgesic use in postoperative care unit and the discharge rate.
Detailed Description
The study is retrospective, including consecutive patients in an unrestricted referral of patients undergoing laparoscopic cholecystectomy, umbilical and inguinal hernia repair. Inclusion period was from 01.04.2013 to 31.03.2015. All patients received general anesthesia using propofol (2 mg/kg) and remifentanil (1 μg/kg/min) for induction. In patients where tracheal intubation was required, this was done without use of neuromuscular blocking drug; otherwise a proseal laryngeal mask was used. For the maintenance of anesthesia, additional continuous infusion of propofol (3-5 mg/kg/h) and remifentanil (0.3-0.5 μg/kg/min) was used. Data were derived from a prospective local database on demographics, anesthetic methods and supplements (i.e. need for neuromuscular blockade) and postoperative needs for supplementary analgesics besides the postoperative standard analgesic regimen, number of hours stayed in the ambulatory surgery department, and discharge rate (including reasons for hospital admittance).
Investigators
Billy B Kristensen
Chief Physician
Hvidovre University Hospital
Eligibility Criteria
Inclusion Criteria
- •patients undergoing laparoscopic cholecystectomy, umbilical and inguinal hernia repair
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of patients requiring neuromuscular blockade
Time Frame: At time of surgery
Data derived from a prospective local database on need for neuromuscular blockade in patients undergoing laparoscopic cholecystectomy, umbilical and inguinal hernia repair.
Secondary Outcomes
- Analgesic use in postoperative care unit(Within 6 hours after surgery)
- Hours stayed in the postoperative care unit(1 to 6 hours after surgery)
- Maximum Visual analog score (VAS) for pain in the postoperative Care unit(1 to 6 hours after surgery)